|
WO2021039748A1
|
|
Diquafosol or salt thereof, and aqueous ophthalmic composition containing polyvinylpyrrolidone
|
|
JP2020169213A
|
|
Epinastine-containing eye drops
|
|
JP2021004090A
|
|
Method for imparting slipperiness to container and use thereof
|
|
WO2020218466A1
|
|
Ophthalmic product and use thereof
|
|
WO2020213693A1
|
|
Lipoic acid prodrug
|
|
JP2020172486A
|
|
Aqueous pharmaceutical composition containing epinastine or salt thereof
|
|
WO2020129965A1
|
|
Agent containing 4-phenylbutyrate, for preventing or treating presbyopia
|
|
JP2020059747A
|
|
Eye drops containing epinastine
|
|
JP2020070297A
|
|
Ophthalmologic composition which suppresses deterioration of soft contact lens
|
|
JP2020059704A
|
|
Ophthalmic composition containing lipophilic component
|
|
WO2020054314A1
|
|
Consultation management system, reminding method, hospital terminal, and program
|
|
WO2020032024A1
|
|
Intraocular lens insertion implement
|
|
WO2020032023A1
|
|
Intraocular lens insertion implement
|
|
WO2020022438A1
|
|
Treatment agent for ophthalmic disease associated with retinal fibrosis
|
|
WO2019245015A1
|
|
Pharmaceutical composition comprising desloratadine or salt thereof
|
|
WO2019176946A1
|
|
Eyedrop-type eyewash composition
|
|
WO2019176947A1
|
|
Pollen bursting-inhibiting composition
|
|
EP3766472A1
|
|
Instillation assistance tool
|
|
EP3760207A1
|
|
Ophthalmic composition comprising diquafosol and cationic polymer
|
|
JP2020132536A
|
|
Aqueous pharmaceutical composition containing cromoglycate or salt thereof
|
